QIX Dividenden Europa
|
17 517,06
|
-131,54
|
-0,75 %
|
Analysen zu QIX Dividenden Europa-Werten
| 06.02.25 | Hannover Rück Neutral | UBS AG | |
| 06.02.25 | Hannover Rück Overweight | JP Morgan Chase & Co. | |
| 06.02.25 | TotalEnergies Buy | UBS AG | |
| 06.02.25 | Roche Sell | Goldman Sachs Group Inc. | |
| 06.02.25 | GSK Neutral | UBS AG | |
| 06.02.25 | TotalEnergies Neutral | Goldman Sachs Group Inc. | |
| 05.02.25 | TotalEnergies Overweight | JP Morgan Chase & Co. | |
| 05.02.25 | GSK Neutral | Goldman Sachs Group Inc. | |
| 05.02.25 | GSK Outperform | Bernstein Research | |
| 05.02.25 | GSK Neutral | UBS AG | |
| 05.02.25 | TotalEnergies Outperform | RBC Capital Markets | |
| 05.02.25 | Allianz Buy | Deutsche Bank AG | |
| 05.02.25 | TotalEnergies Buy | UBS AG | |
| 05.02.25 | TotalEnergies Neutral | Goldman Sachs Group Inc. | |
| 05.02.25 | GSK Underweight | JP Morgan Chase & Co. | |
| 04.02.25 | Iberdrola Sector Perform | RBC Capital Markets | |
| 04.02.25 | Iberdrola Neutral | JP Morgan Chase & Co. | |
| 04.02.25 | Roche Sell | Deutsche Bank AG | |
| 04.02.25 | Mercedes-Benz Group Neutral | Goldman Sachs Group Inc. | |
| 03.02.25 | Mercedes-Benz Group Market-Perform | Bernstein Research | |
| 03.02.25 | Roche Underweight | JP Morgan Chase & Co. | |
| 03.02.25 | Mercedes-Benz Group Outperform | RBC Capital Markets | |
| 03.02.25 | Hennes & Mauritz AB Underperform | Bernstein Research | |
| 03.02.25 | Hennes & Mauritz AB Sector Perform | RBC Capital Markets | |
| 03.02.25 | Mercedes-Benz Group Hold | Jefferies & Company Inc. | |
| 31.01.25 | Roche Sell | Deutsche Bank AG | |
| 31.01.25 | Roche Neutral | UBS AG | |
| 31.01.25 | Hennes & Mauritz AB Sell | Goldman Sachs Group Inc. | |
| 30.01.25 | Hennes & Mauritz AB Underweight | JP Morgan Chase & Co. | |
| 30.01.25 | DHL Group Overweight | JP Morgan Chase & Co. | |
| 30.01.25 | GSK Underweight | JP Morgan Chase & Co. | |
| 30.01.25 | Mercedes-Benz Group Neutral | Goldman Sachs Group Inc. | |
| 30.01.25 | Roche Outperform | Bernstein Research | |
| 30.01.25 | GSK Neutral | UBS AG | |
| 30.01.25 | Roche Underweight | JP Morgan Chase & Co. | |
| 30.01.25 | Roche Neutral | UBS AG | |
| 30.01.25 | Roche Sell | Goldman Sachs Group Inc. | |
| 30.01.25 | Hennes & Mauritz AB Buy | UBS AG | |
| 30.01.25 | Hennes & Mauritz AB Sell | Goldman Sachs Group Inc. | |
| 30.01.25 | Hennes & Mauritz AB Sector Perform | RBC Capital Markets |
HOT STOCKS DER LETZTEN 3 TAGE
| Hannover Rück | 6 |
| GSK | 3 |
| Roche | 3 |
| DHL Group | 2 |
| Siemens | 1 |
| Hennes & Mauritz AB | 1 |
| Mercedes-Benz Group | 1 |
Analysen zu Aktien folgender Indizes
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.